innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

March 28, 2016 – Dr. Roger L. Garceau, the former Executive Vice President and Chief Medical Officer (CMO) of NPS Pharmaceuticals, Inc. was appointed to Entera’s board of directors. Dr. Garceau brings more than 30 years of experience to Entera's board. Dr. Garceau served in a number of senior leadership positions at Sanofi-Aventis as well as in other pharmaceutical companies.